For the past month, Johnson & Johnson's (JNJ 1.68%) share price has followed the long-term trend in health care spending, moving steadily up and to the right. With shares now sitting near their 52-week and all-time highs, our health-care bureau chief Brenton Flynn was anxiously awaiting today's earnings report to take a pulse on the $200 billion health care giant.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.